These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27168837)

  • 1. Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery.
    Cao Y; Wang F; Liu Z; Jiao B
    Exp Ther Med; 2016 May; 11(5):1977-1982. PubMed ID: 27168837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
    Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
    Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary function in prolactinoma. Effect of surgery and postoperative bromocriptine therapy.
    Pelkonen R; Grahne B; Hirvonen E; Karonen SL; Salmi J; Tikkanen M; Valtonen S
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):335-48. PubMed ID: 7261416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up.
    Wu ZB; Yu CJ; Su ZP; Zhuge QC; Wu JS; Zheng WM
    J Neurosurg; 2006 Jan; 104(1):54-61. PubMed ID: 16509147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological changes of prolactinomas treated with bromocriptine].
    Teramoto A; Takakura K; Fukushima T; Osamura Y
    No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant prolactinomas: clinical management and long-term follow up.
    Shrivastava RK; Arginteanu MS; King WA; Post KD
    J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transsphenoidal surgery for pituitary adenomas in children.
    Dyer EH; Civit T; Visot A; Delalande O; Derome P
    Neurosurgery; 1994 Feb; 34(2):207-12; discussion 212. PubMed ID: 8177379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
    Becker G; Kocher M; Kortmann RD; Paulsen F; Jeremic B; Müller RP; Bamberg M
    Strahlenther Onkol; 2002 Apr; 178(4):173-86. PubMed ID: 12040754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence.
    Abe T; Lüdecke DK
    Surg Neurol; 2002 Jun; 57(6):369-78; discussion 378-9. PubMed ID: 12176193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
    Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
    Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolactin producing adenoma].
    Tamaki N; Yonezawa K
    Nihon Rinsho; 1993 Oct; 51(10):2685-90. PubMed ID: 8254940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
    Takahashi T; Kuwayama A; Katoh T; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1336-51. PubMed ID: 3817228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.